• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Store
  • ION Awards
  • Podcasts
  • Full Measure
    • Full Measure Cover Stories
  • Donate
  • Bestseller "Slanted"

Sharyl Attkisson

Untouchable Subjects. Fearless, Nonpartisan Reporting.

  • US
  • World
  • Business
  • Health
    • Vaccine, Medical links
    • Omicron Lab Origin
    • Covid-19 Origins
    • Covid-19 Natural Immunity
    • Covid-19 Vaccine Concerns Summary
    • Covid-19 Vaccine: 80 Common Adverse Events
  • The Censored
  • Special Investigations
    • Attkisson v. DOJ
    • Media Mistakes, Biden Era
    • Media Mistakes on Trump
    • Other investigations
      • Benghazi
      • "Collusion v. Trump" TL
      • Election 2020
      • Fake News
      • Fast & Furious
      • Obamacare
      • Obama Surveillance TL
      • Other investigations
      • Ukraine 'Sabotage' of Trump TL

(READ) FDA approves new drug for autoimmune lupus disorder SLE

Dated: August 21, 2021 by Sharyl Attkisson Leave a Comment

      

The FDA has approved a new drug from Astra Zeneca to treat some patients with systemic lupus erythematosus (SLE). It's the first approved drug of its kind, and the only new treatment for SLE in more than a decade, according to Astra Zeneca.

SLE is a form of autoimmune disorder affecting more than 300,000 people in the U.S.

The drug is anifrolumab, an inhibitor of type 1 interferons. It will be sold as Saphnelo.

According to Astra Zeneca: "Saphnelo is a first-in-class type I interferon receptor antibody and the only new medicine in over a decade for patients with systemic lupus erythematosus."

In studies, the drugmaker says more patients treated with Saphnelo had "a reduction in overall disease activity across organ systems, including skin and joints, and achieved sustained reduction in oral corticosteroid (OCS) use compared to placebo, with both groups receiving standard therapy."

Common adverse events during the studies reportedly included: "nasopharyngitis, upper respiratory tract infection, bronchitis, infusion-related reactions, herpes zoster and cough."

Read more at the link below:

https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2021/saphnelo-approved-in-the-us-for-sle.html


      
[the_ad id="17661"]

About Sharyl Attkisson

Emmy-Award Winning Investigative Journalist, New York Times Best Selling Author, Host of Sinclair's Full Measure

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Coming Soon

The Bad Shirts: High-Quality, Wearable Humor

The Sharyl Attkisson Store

Buy Great, Original Products & Support Independent Journalism

Subscribe

Get the Latest Stories Straight to Your Inbox

SUBSCRIBE TO SHARYL’S RUMBLE CHANNEL


Follow Sharyl Attkisson

  • Facebook
  • Instagram
  • RSS
  • Twitter
  • YouTube



Footer

Pages

  • Home
  • About
  • Podcast
  • Support
  • Contact

Sitemap

2ndary Pages

  • Full Measure Stations
  • Privacy Policy
  • Terms of Use
  • Newsletter
  • Returns & Refunds Policy

SPECIAL INVESTIGATIONS

  • Attkisson v. DOJ/FBI
  • Benghazi
  • Election 2020
  • Fake News
  • Fast & Furious
  • Obamacare

Copyright © 2023 ยท Log in